Compare LEU & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEU | MMSI |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 1998 | 1996 |
| Metric | LEU | MMSI |
|---|---|---|
| Price | $139.67 | $85.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $247.40 | $101.45 |
| AVG Volume (30 Days) | ★ 663.4K | 446.6K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | 1.21 | ★ 1.33 |
| Revenue | $193,000,000.00 | ★ $1,515,906,000.00 |
| Revenue This Year | $5.09 | $7.95 |
| Revenue Next Year | $0.26 | $6.07 |
| P/E Ratio | $121.67 | ★ $64.05 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $135.75 | $59.74 |
| 52 Week High | $464.00 | $94.75 |
| Indicator | LEU | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 45.47 |
| Support Level | N/A | $84.66 |
| Resistance Level | $193.83 | $88.14 |
| Average True Range (ATR) | 6.36 | 1.95 |
| MACD | 0.73 | -0.23 |
| Stochastic Oscillator | 17.62 | 35.94 |
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.